August 11, 2026 07:00 ET | Source: Dark Horse Consulting Group WALNUT CREEK, Calif. and SHANGHAI, Aug. 11, 2026 (GLOBE NEWSWIRE) — Dark Horse Consulting Group (DHCG), a leading life sciences consulting firm specializing in advanced therapies, today announced the formation of Dark Horse Consulting China and the appointment of Kang Liu, Ph.D. as its inaugural hire. […]
August 11, 2026 06:00 ET | Source: Zymeworks Inc. VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: About Zymeworks Inc. Zymeworks
August 11, 2026 05:00 ET | Source: Boehringer Ingelheim Boehringer Ingelheim announced today that it has acquired Evax AG, a Swiss biotech company focused on equine health. Founded more than a decade ago at the University of Zurich, Evax has been exploring the use of therapeutic vaccines to address significant unmet needs in horses, particularly for the treatment of allergic skin
August 11, 2026 02:00 ET | Source: Royal Philips August 11, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Exor N.V. today announced that they have agreed to update their long-term relationship agreement. It provides Exor with the flexibility to increase its shareholding in Philips to up
The intelligent sleep wearable combines 3D light-blocking technology, adjustable temperature control, and immersive audio to create a personalized sleep environment. August 10, 2026 23:21 ET | Source: DR H HONG KONG, Aug. 11, 2026 (GLOBE NEWSWIRE) — Smart wearable brand DR H has officially launched the Mind Ease Mask, an intelligent sleep wearable integrating light management, temperature control, and
Next-generation all-in-one performance supplement brand, built on a radical athlete co-ownership model, opens pre-sales ahead of September 2026 product launch August 10, 2026 20:00 ET | Source: NORTH Performance DOVER, Del., Aug. 10, 2026 (GLOBE NEWSWIRE) — NORTH Performance, a next-generation all-in-one performance supplement brand built on the radical premise that athletes shouldn’t be ambassadors; they should
August 10, 2026 07:00 ET | Source: Curium BOSTON and LIEGE, Belgium, Aug. 10, 2026 (GLOBE NEWSWIRE) — Curium™ a leading global radiopharmaceutical company, announced that it has completed the acquisition of Abscint SA, a Belgian clinical-stage radiopharmaceutical company developing innovative diagnostic imaging agents for oncology. Through the transaction, Curium has acquired the global rights to develop,
August 06, 2026 09:00 ET | Source: Royal Philips August 6, 2026 New collaborations expand wearable and out-of-hospital monitoring capabilities, helping support continuous patient visibility from admission through recovery at home Amsterdam, Netherlands. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree
Investigators Present Data Supporting Disease-Modifying Potential of the Io Therapeutics RXR Agonist Compound IRX4204 in Parkinson’s Disease August 05, 2026 12:30 ET | Source: Io Therapeutics, Inc. SPRING, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) — Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas, announced today the presentation of new research demonstrating that IRX4204,
To mark World Breastfeeding Week, Medela announces the recipient of its research contribution and launches a month-long campaign highlighting evidence-based lactation care August 04, 2026 08:00 ET | Source: Medela Baar, Switzerland, Aug. 04, 2026 (GLOBE NEWSWIRE) — Baar, Switzerland, August 4, 2026 – To mark World Breastfeeding Week (WBW), observed globally from August 1–7, Medela, the brand trusted by
August 04, 2026 08:00 ET | Source: Cirrus Therapeutics, Inc. CAMBRIDGE, Mass. and SINGAPORE, Aug. 04, 2026 (GLOBE NEWSWIRE) — Cirrus Therapeutics, an ocular immunology biotech, today announced a collaboration with Singapore Eye Research Institute (SERI) and Duke-NUS Medical School (Duke-NUS). Cirrus also announced an expanded investor syndicate, including Cedars Sinai Intellectual Property Company, raising $14.7 million
August 03, 2026 07:31 ET | Source: Lantheus Holdings, Inc. BOSTON and BEDFORD, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) — Curium™, a leading, global radiopharmaceutical company with proven expertise in the development, manufacturing and supply of radiopharmaceuticals that improve the way cancer is diagnosed and treated, and Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), today announced
July 29, 2026 10:00 ET | Source: Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been granted De Novo classification by the U.S. Food & Drug Administration (FDA) for its TESSA Spatial Surgery System. Utilizing cutting-edge accelerated computing and AI technology, the TESSA (Tracking Enabled Spatial Surgery Assistant)
Nature Communications Publishes Breakthrough Study Showing How COVID-Era Immune Memory Can Be Redirected to Fight Cancer July 28, 2026 17:37 ET | Source: Celloram Inc. Celloram, Inc., University Hospitals, and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients. CLEVELAND, July 28, 2026 (GLOBE NEWSWIRE) — In
July 28, 2026 16:12 ET | Source: Alamar Biosciences, Inc. Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging Highly sensitive multiplex measurement captures regulatory proteins, like checkpoint inhibitors, and low abundance targets that standard platforms routinely miss FREMONT, Calif., July 28, 2026
